Company profile
Inotiv, Inc.
PNK: NOTVQ · Healthcare · Medical - Diagnostics & Research
#208 of 1,418 Healthcare companies by revenue48th-percentile growth
EA Score
63CFH 60DQ 80GM 36SS 68
v0.1 · 65/100 weight · provisional
↑ disclosure history, workforce scale · ↓ growth stability, market scale
Methodology →Revenue TTM
$507.4M
Rev growth YoY (TTM)
+5.6%
Net income (FY)
-$68.6M
Employees
1,945
as of 2026-08-27
Market cap
$390.4k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$513.0M$513.0M2025
Net income-$68.6M-$68.6M2025
Operating income-$30.9M-$30.9M2025
Total assets$771.1M$771.1M2025
Liabilities$635.1M$635.1M2025
Equity$136.0M$136.0M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product55%
Service45%
By geography
UNITED STATES93%
NETHERLANDS7%
The read
What is Inotiv, Inc.’s revenue?
Inotiv, Inc. booked $513.0M in FY2025 revenue, growing 4.5% year over year — about the middle of the pack among Healthcare companies we track, at a -13.4% net margin.
Peers · Healthcare
AtriCure, Inc.84B+Mirum Pharmaceuticals, Inc.64CVeracyte, Inc.82B+ADMA Biologics, Inc.85AGlaukos Corporation71BThe Oncology Institute, Inc.52DKey facts
CEORobert W. Leasure Jr.
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersWest Lafayette, IN
ExchangePNK: NOTVQ
Employees1,945
IPO date1997-11-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.